{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:42:51Z","timestamp":1784544171708,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Sanofi"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-024-11684-8","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T13:01:54Z","timestamp":1728565314000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Introduction of a hexavalent vaccine containing acellular pertussis into the national immunization program for infants in Peru: a cost-consequence analysis of vaccination coverage"],"prefix":"10.1186","volume":"24","author":[{"given":"Janice","family":"Seinfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Sobrevilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Laura","family":"Rosales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Iba\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar","family":"Munayco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,10]]},"reference":[{"issue":"9","key":"11684_CR1","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1080\/21645515.2015.1044180","volume":"11","author":"K Maman","year":"2015","unstructured":"Maman K, Z\u00f6llner Y, Greco D, Duru G, Sendyona S, Remy V. The value of childhood combination vaccines: from beliefs to evidence. Hum Vaccin Immunother. 2015;11(9):2132\u201341.","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"11684_CR2","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/INF.0b013e31805d7f17","volume":"26","author":"GS Marshall","year":"2007","unstructured":"Marshall GS, Happe LE, Lunacsek OE, Szymanski MD, Woods CR, Zahn M, Russell A. Use of combination vaccines is associated with improved coverage rates. Pediatr Infect Dis J. 2007;26(6):496\u2013500.","journal-title":"Pediatr Infect Dis J"},{"key":"11684_CR3","unstructured":"Ministerio de Salud, MINSA. Technical Norm N\u00aa196-2022-MINSA. 2023"},{"key":"11684_CR4","unstructured":"World Health Organization: Global Routine Immunization Strategies and Practices (GRISP): A Companion Document to the Global Vaccine Action Plan (GVAP). 2016 Avilable at: https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/essential-programme-on-immunization\/implementation\/global-routine-immunization-strategies-and-practices-(grisp). Accessed 11 Jun 2023."},{"key":"11684_CR5","unstructured":"United Nations Children\u2019s Fund (UNICEF). Peru: WHO and UNICEF estimates of immunization coverage: 2021 revision. https:\/\/data.unicef.org\/resources\/immunization-country-profiles\/. Accessed 11 Jun 2023."},{"key":"11684_CR6","unstructured":"Instituto Nacional de Estad\u00edstica e Inform\u00e1tica. Per\u00fa: Encuesta Demogr\u00e1fica y de Salud Familiar - ENDES 2019. https:\/\/www.inei.gob.pe\/media\/MenuRecursivo\/publicaciones_digitales\/Est\/Endes2019\/. Accessed 11 Jun 2023."},{"key":"11684_CR7","unstructured":"Instituto Nacional de Estad\u00edstica e Inform\u00e1tica. Per\u00fa: Encuesta Demogr\u00e1fica y de Salud Familiar - ENDES 2020. https:\/\/www.inei.gob.pe\/media\/MenuRecursivo\/publicaciones_digitales\/Est\/Lib1795\/\u00a0. Accessed 11 Jun 2023."},{"key":"11684_CR8","unstructured":"Instituto Nacional de Estad\u00edstica e Inform\u00e1tica: Per\u00fa: Encuesta Demogr\u00e1fica y de Salud Familiar - ENDES 2022. 2023, https:\/\/www.gob.pe\/institucion\/inei\/informes-publicaciones\/4233597-peru-encuesta-demografica-y-de-salud-familiar-endes-2022. Accessed 13 Sep 2023."},{"key":"11684_CR9","unstructured":"Mesa de Concertaci\u00f3n para la Lucha contra la Pobreza. Per\u00fa: El caso del ni\u00f1o con poliovirus derivado de vacuna tipo 1 en la provincia de Datem del Mara\u00f1\u00f3n - Departamento de Loreto. 2023."},{"key":"11684_CR10","unstructured":"Organizaci\u00f3n Panamericana de la Salud: Poliomielitis. https:\/\/www.paho.org\/es\/temas\/poliomielitis\u00a0. Accessed 15 Aug 2024."},{"issue":"4","key":"11684_CR11","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1517\/14712598.2013.774368","volume":"13","author":"MC Nunes","year":"2013","unstructured":"Nunes MC, Madhi SA. Review of a new fully liquid, hexavalent vaccine: Hexaxim. Expert Opin Biol Ther. 2013;13(4):575\u201393.","journal-title":"Expert Opin Biol Ther"},{"issue":"11","key":"11684_CR12","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1080\/14760584.2017.1383157","volume":"16","author":"S Wang","year":"2017","unstructured":"Wang S, Tafalla M, Hanssens L, Dolhain J. A review of Haemophilus influenzae disease in Europe from 2000\u20132014: challenges, successes and the contribution of hexavalent combination vaccines. Expert Rev Vaccines. 2017;16(11):1095\u2013105.","journal-title":"Expert Rev Vaccines"},{"key":"11684_CR13","unstructured":"Ministerio de Salud de Chile. Programa nacional de inmunizaciones. Calendario de vacunaci\u00f3n 2022. https:\/\/www.minsal.cl\/programa-nacional-de-inmunizaciones\u00a0. Accessed 11 Jun 2023."},{"key":"11684_CR14","unstructured":"Ministerio de Salud P\u00fablica y Bienestar Social: La vacuna hexavalente acelular llega para proteger a los ni\u00f1os de Paraguay contra 6 enfermedades. 2023, https:\/\/pai.mspbs.gov.py\/la-vacuna-hexavalente-acelular-llega-para-proteger-a-los-ninos-de-paraguay-contra-6-enfermedades\/#:~:text=Nuevo%20esquema&text=Paraguay%20es%20el%20cuarto%20pa%C3%ADs,ahora%20Paraguay%20en%20el%202023. Accessed 17 Aug 2024."},{"key":"11684_CR15","unstructured":"UNICEF El Salvador: El Ministerio de Salud incluye nuevas vacunas dentro del esquema nacional de vacunaci\u00f3n 2023 con el apoyo de UNICEF. 2023, https:\/\/www.unicef.org\/elsalvador\/comunicados-prensa\/ministerio-de-salud-incluye-nuevas-vacunas-dentro-de-esquema-nacional. Accessed 17 Aug 2024."},{"issue":"1","key":"11684_CR16","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1186\/s12913-022-08006-1","volume":"22","author":"J Seinfeld","year":"2022","unstructured":"Seinfeld J, Rosales ML, Sobrevilla A, L\u00f3pez Yescas JG. Economic assessment of incorporating the hexavalent vaccine as part of the National Immunization Program of Peru. BMC Health Serv Res. 2022;22(1):651.","journal-title":"BMC Health Serv Res"},{"key":"11684_CR17","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.vhri.2021.06.001","volume":"26","author":"M Romero","year":"2021","unstructured":"Romero M, G\u00f3ngora DS, Caicedo ML, Benchabane D, Lopez JG. Cost-minimization and Budget Impact Analysis of a Hexavalent Vaccine (Hexaxim\u00ae) in the Colombian expanded program on immunization. Value Health Reg Issues. 2021;26:150\u20139.","journal-title":"Value Health Reg Issues"},{"issue":"1","key":"11684_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12913-020-05115-7","volume":"20","author":"I Olivera","year":"2020","unstructured":"Olivera I, Grau C, Dibarboure H, Torres JP, Mieres G, Lazarov L, Alvarez FP, Yescas JGL. Valuing the cost of improving Chilean primary vaccination: a cost minimization analysis of a hexavalent vaccine. BMC Health Serv Res. 2020;20(1):295.","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"11684_CR19","doi-asserted-by":"publisher","first-page":"224","DOI":"10.4067\/S0716-10182021000200224","volume":"38","author":"A Gentile","year":"2021","unstructured":"Gentile A, Giglio N, Castellano V, L\u00f3pez J, Dibarboure H. Vaccination in children under 1 year with pertussis component in the context of the global initiative for the eradication of Poliomyelitis in Argentina: economic analysis. Revista Chil De infectolog\u00eda. 2021;38(2):224\u201331.","journal-title":"Revista Chil De infectolog\u00eda"},{"key":"11684_CR20","unstructured":"de Salud M. MINSA. Repositorio \u00danico Nacional de Informaci\u00f3n en Salud - Reunis. 2021. https:\/\/drive.minsa.gob.pe\/s\/qGjApnEJxeCdE4q. Accessed 11 Jun 2023."},{"issue":"43","key":"11684_CR21","doi-asserted-by":"publisher","first-page":"6704","DOI":"10.1016\/j.vaccine.2020.08.046","volume":"38","author":"M O\u2019Ryan","year":"2020","unstructured":"O\u2019Ryan M, Calvo AE, Espinoza M, Vega N, Lagomarcino AJ, L\u00f3pez Castillo H, Puentes E, Macina D. Parent reported outcomes to measure satisfaction, acceptability, and daily life impact after vaccination with whole-cell and acellular pertussis vaccine in Chile. Vaccine. 2020;38(43):6704\u201313.","journal-title":"Vaccine"},{"issue":"4","key":"11684_CR22","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1093\/heapol\/czab026","volume":"36","author":"E Clarke-Deelder","year":"2021","unstructured":"Clarke-Deelder E, Suharlim C, Chatterjee S, Brenzel L, Ray A, Cohen JL, McConnell M, Resch SC, Menzies NA. Impact of campaign-style delivery of routine vaccines: a quasi-experimental evaluation using routine health services data in India. Health Policy Plan. 2021;36(4):454\u201363.","journal-title":"Health Policy Plan"},{"key":"11684_CR23","unstructured":"Serum Institute of India Pvt Ltd. Diphtheria, Tetanus, Pertussis (whole cell), Hepatitis B and Haemophilus influenzae type b Conjugate Vaccine Adsorbed (product insert). 2010."},{"key":"11684_CR24","unstructured":"Sanofi Pasteur. Imovax Polio suspension for injection in multidose vial. Poliomyelitis vaccine (inactivated) (product insert). 2017."},{"key":"11684_CR25","volume-title":"Hexaxim suspension for injection. Diphtheria, tetanus, pertussis (acellular, component), hepatitis b (andr), Poliomyelitis (inactivated) and haemophilus influenzae type b conjugate vaccine (adsorbed) (product insert)","author":"Sanofi Pasteur","year":"2018","unstructured":"Sanofi Pasteur. Hexaxim suspension for injection. Diphtheria, tetanus, pertussis (acellular, component), hepatitis b (andr), Poliomyelitis (inactivated) and haemophilus influenzae type b conjugate vaccine (adsorbed) (product insert). 2018."},{"key":"11684_CR26","volume-title":"Poliomyelitis Vaccine (oral): Bivalent type 1 and 3 (product insert)","author":"Serum Institute of India Pvt Ltd","year":"2014","unstructured":"Serum Institute of India Pvt Ltd. Poliomyelitis Vaccine (oral): Bivalent type 1 and 3 (product insert). 2014."},{"key":"11684_CR27","unstructured":"Secretaria De Salud: Manual de eventos supuestamente atribuibles a la vacunaci\u03ccn o immunizaci\u03ccn. 2014, https:\/\/www.gob.mx\/cms\/uploads\/attachment\/file\/287240\/ESAVI_2014.pdf\u00a0. Accessed 13 Sep 2023."},{"issue":"1","key":"11684_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00431-001-0853-0","volume":"161","author":"O Zent","year":"2002","unstructured":"Zent O, Arras-Reiter C, Broeker M, Hennig R. Immediate allergic reactions after vaccinations\u2013a post-marketing surveillance review. Eur J Pediatr. 2002;161(1):21\u20135.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"11684_CR29","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jaci.2017.12.971","volume":"141","author":"MM McNeil","year":"2018","unstructured":"McNeil MM, DeStefano F. Vaccine-associated hypersensitivity. J Allergy Clin Immunol. 2018;141(2):463\u201372.","journal-title":"J Allergy Clin Immunol"},{"key":"11684_CR30","volume-title":"Salud P\u00fablica de Cuba: Ficha t\u00e9cnica de Heberpenta","author":"de Ministerio","year":"2010","unstructured":"de Ministerio. Salud P\u00fablica de Cuba: Ficha t\u00e9cnica de Heberpenta. 2010."},{"issue":"40","key":"11684_CR31","doi-asserted-by":"publisher","first-page":"6007","DOI":"10.1016\/j.vaccine.2018.08.022","volume":"36","author":"J Patterson","year":"2018","unstructured":"Patterson J, Kagina BM, Gold M, Hussey GD, Muloiwa R. Comparison of adverse events following immunisation with acellular and whole-cell pertussis vaccines: a systematic review. Vaccine. 2018;36(40):6007\u201316.","journal-title":"Vaccine"},{"issue":"4","key":"11684_CR32","doi-asserted-by":"publisher","first-page":"461","DOI":"10.4067\/S0716-10182019000400461","volume":"36","author":"O Thomsen","year":"2019","unstructured":"Thomsen O, Salda\u00f1a A, Cerda J, Abarca K. Seguridad en vacunas: descripci\u00f3n de Los eventos adversos notificados Al Sistema De vigilancia en Chile, 2014 a 2016. Rev Chil Infect. 2019;36(4):461\u20138.","journal-title":"Rev Chil Infect"},{"key":"11684_CR33","doi-asserted-by":"crossref","unstructured":"Zafack JG, De Serres G, Kiely M, Gari\u00e9py MC, Rouleau I, Top KA. Risk of recurrence of adverse events following immunization: a systematic review. Pediatrics 2017;140(3):e20163707.","DOI":"10.1542\/peds.2016-3707"},{"key":"11684_CR34","unstructured":"Minsterio de Salud Per\u00fa. Centro Nacional de Epidemiologia, Prevencion y Control de Enfermedades. Epidemiological surveillance. Avilable at: https:\/\/www.dge.gob.pe\/portalnuevo\/salas-situacionales\/sala-de-situacion-nacional\/#tab-content-2"},{"key":"11684_CR35","unstructured":"Instituto Nacional de Estad\u00edstica e Inform\u00e1tica. Estad\u00edsticas de Econom\u00eda - ENDES 2022. https:\/\/www.inei.gob.pe\/estadisticas\/indice-tematico\/economia\/#url\u00a0. Accessed 11 Jun 2023."},{"key":"11684_CR36","unstructured":"Banco Central de Reserva del Per\u00fa. Informe de la Encuesta Mensual de Expectativas Macroecon\u00f3micas: Febrero 2022. 2022. https:\/\/www.bcrp.gob.pe\/estadisticas\/encuesta-de-expectativas-macroeconomicas.html\u00a0. Accessed 11 Jun 2023."},{"key":"11684_CR37","unstructured":"Superintendecia de Banca. Seguros Y AFP Rep\u00fablica del Per\u00fa. Cotizaci\u00f3n de oferta y demanda tipo de cambio promedio ponderado. https:\/\/www.sbs.gob.pe\/app\/pp\/sistip_portal\/paginas\/publicacion\/tipocambiopromedio.aspx. Accessed 11 Jun 2023."},{"key":"11684_CR38","unstructured":"Organiza\u00e7\u00e3o Pan-Americana da Sa\u00fade (OPAS): Vacunas: Fondo Rotatorio. 2020, https:\/\/www3.paho.org\/hq\/index.php?option=com_docman&view=list&format=html&layout=default&slug=vacunas-9980&Itemid=270\u27e8=pt#gsc.tab=0\u00a0. Accessed 13 Sep 2023."},{"key":"11684_CR39","unstructured":"Organiza\u00e7\u00e3o Pan-Americana da Sa\u00fade (OPAS): Precios del Fondo Rotatorio. 2023, https:\/\/www.paho.org\/es\/tag\/precios-fondo-rotatorio?topic=4823&d%5Bmin%5D=2015-01-15&d%5Bmax%5D=2023-08-15\u00a0. Accessed 13 Sep 2023."},{"issue":"2","key":"11684_CR40","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/INF.0b013e318187d047","volume":"28","author":"LE Happe","year":"2009","unstructured":"Happe LE, Lunacsek OE, Kruzikas DT, Marshall GS. Impact of a pentavalent combination vaccine on immunization timeliness in a state Medicaid population. Pediatr Infect Dis J. 2009;28(2):98\u2013101.","journal-title":"Pediatr Infect Dis J"},{"issue":"46","key":"11684_CR41","doi-asserted-by":"publisher","first-page":"5495","DOI":"10.1016\/j.vaccine.2016.09.038","volume":"34","author":"KN Nelson","year":"2016","unstructured":"Nelson KN, Wallace AS, Sodha SV, Daniels D, Dietz V. Assessing strategies for increasing urban routine immunization coverage of childhood vaccines in low and middle-income countries: a systematic review of peer-reviewed literature. Vaccine. 2016;34(46):5495\u2013503.","journal-title":"Vaccine"},{"issue":"11","key":"11684_CR42","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1080\/21645515.2021.1965424","volume":"17","author":"F Aguirre-Boza","year":"2021","unstructured":"Aguirre-Boza F, San Mart\u00edn PP, Valenzuela BMT. How were DTP-related adverse events reduced after the introduction of an acellular pertussis vaccine in Chile? Hum Vaccin Immunother. 2021;17(11):4225\u201334.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"11684_CR43","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4314\/star.v2i1.98842","volume":"2","author":"H Mohammed","year":"2013","unstructured":"Mohammed H, Atomsa A. Assessment of child immunization coverage and associated factors in Oromia regional state, eastern Ethiopia. Sci Technol Arts Res J. 2013;2(1):36\u201341.","journal-title":"Sci Technol Arts Res J"},{"key":"11684_CR44","unstructured":"Chavez Y. Factores que influyen en el abandono del calendario de vacunaci\u00f3n en madres de ni\u00f1os menores de 5 a\u00f1os. Lima: Universidad San Mart\u00edn de Porres; 2017. Available at: https:\/\/repositorio.usmp.edu.pe\/handle\/20.500.12727\/2692\u00a0. Accessed 11 Jun 2023."},{"key":"11684_CR45","doi-asserted-by":"publisher","first-page":"1924941","DOI":"10.1155\/2019\/1924941","volume":"2019","author":"A Girmay","year":"2019","unstructured":"Girmay A, Dadi AF. Full Immunization coverage and associated factors among children aged 12\u201323 months in a hard-to-reach areas of Ethiopia. Int J Pediatr. 2019;2019:1924941.","journal-title":"Int J Pediatr"},{"issue":"6","key":"11684_CR46","doi-asserted-by":"publisher","first-page":"e593","DOI":"10.1016\/S2214-109X(17)30184-5","volume":"5","author":"MA Habib","year":"2017","unstructured":"Habib MA, Soofi S, Cousens S, Anwar S, Haque NU, Ahmed I, Ali N, Tahir R, Bhutta ZA. Community engagement and integrated health and polio immunisation campaigns in conflict-affected areas of Pakistan: a cluster randomised controlled trial. Lancet Glob Health. 2017;5(6):e593\u2013603.","journal-title":"Lancet Glob Health"},{"issue":"4","key":"11684_CR47","doi-asserted-by":"publisher","first-page":"e053236","DOI":"10.1136\/bmjopen-2021-053236","volume":"12","author":"MM Khan","year":"2022","unstructured":"Khan MM, Vargas-Zambrano JC, Coudeville L. How did the adoption of wP-pentavalent affect the global paediatric vaccine coverage rate? A multicountry panel data analysis. BMJ Open. 2022;12(4):e053236.","journal-title":"BMJ Open"},{"issue":"6","key":"11684_CR48","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/01.inf.0000222413.47344.23","volume":"25","author":"H Kalies","year":"2006","unstructured":"Kalies H, Grote V, Verstraeten T, Hessel L, Schmitt HJ, von Kries R. The use of combination vaccines has improved timeliness of vaccination in children. Pediatr Infect Dis J. 2006;25(6):507\u201312.","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"11684_CR49","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1080\/21645515.2017.1362515","volume":"13","author":"SK Kurosky","year":"2017","unstructured":"Kurosky SK, Davis KL, Krishnarajah G. Effect of combination vaccines on completion and compliance of childhood vaccinations in the United States. Hum Vaccin Immunother. 2017;13(11):2494\u2013502.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"11684_CR50","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12913-021-07428-7","volume":"22","author":"SM Aljunid","year":"2022","unstructured":"Aljunid SM, Al Bashir L, Ismail AB, Aizuddin AN, Rashid S, Nur AM. Economic impact of switching from partially combined vaccine Pentaxim\u00ae and hepatitis B to fully combined vaccine Hexaxim\u00ae\u00a0in the Malaysian National Immunization Program. BMC Health Serv Res. 2022;22(1):34.","journal-title":"BMC Health Serv Res"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-024-11684-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-024-11684-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-024-11684-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T01:03:02Z","timestamp":1728608582000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-024-11684-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,10]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["11684"],"URL":"https:\/\/doi.org\/10.1186\/s12913-024-11684-8","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,10]]},"assertion":[{"value":"17 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data used for the study is publicly available and therefore ethics approval was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors are employees of Videnza Consultores who were contracted by Sanofi to conduct this research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1216"}}